Clinical Significance of Extended-Spectrum ![]() |
Park, Cheol
(Department of Pediatrics, Korea University)
Kim, Min-Sang (Department of Pediatrics, Korea University) Kim, Mi-Kyung (Department of Pediatrics, Korea University) Yim, Hyung-Eun (Department of Pediatrics, Korea University) Yoo, Kee-Hwan (Department of Pediatrics, Korea University) Hong, Young-Sook (Department of Pediatrics, Korea University) Lee, Joo-Won (Department of Pediatrics, Korea University) |
1 |
Hirakata Y, Matsuda J, Miyazaki Y, Kamihira S, Kawakami S, Miyazawa Y, et al. Regional variation in the prevalence of extended-spectrum |
2 |
Du Bois SK, Marriot MS, Amyes S.G.B. TEM- and SHV-derived extended-spectrum |
3 | Knothe H, Shah P, Kremery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983;11:315-7. DOI ScienceOn |
4 | Jacoby GA. Extended-spectrum beta-lactamases and other enzymes providing resistance to oxymino-beta-lactams. Infect Dis Clin North Am 1997;11:875-87. DOI ScienceOn |
5 | Paterson DL, Bonomo RA. Extended-spectrum betalactamases: a clinical update. Clin Microbiol Rev 2005;18:657-86 DOI ScienceOn |
6 |
Jarlier N, Nicolas M-H, Fournier G, Philippon A. Extended broad-spectrum |
7 | Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamase and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39:211-33. |
8 | Cantón R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, et al. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008;1:144-53. |
9 | Hoberman A, Charron M, Hickey RW, Baskin M, Kearney DH, Wald ER. Imaging studies after a first febrile urinary tract infection in young children. N Engl J Med 2003;348:195-202. DOI ScienceOn |
10 | American academy of pediatrics, committee on quality improvement, subcommittee on urinary tract infection. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. Pediatrics 1999;103:843-51. |
11 | Jacobson SH, Eklof O, Eriksson CG, Lins LE, Tidgren B, Winberg J. Development of hypertension and uraemia after pyelonephritis in childhood: 27 year follow up. BMJ 1989; 299:703-6. DOI ScienceOn |
12 | Prajapati BS, Prajapati RB, Patel PS. Advances in management of urinary tract infections. Indian J Pediatr 2008;75:809-14. DOI ScienceOn |
13 | Lee SY, Lee JH, Kim JH, Hur JK, Kim SM, Ma SH, et al. Susceptibility tests of oral antibiotics including cefixime against Escherichia coli, isolated from pediatric patients with community acquired urinary tract infections. Korean J Pediatr 2006;49:777-83. DOI |
14 | Oteo J, Perez-Vazquez M, Campos J. Extended-spectrum b-lactamase-producing Escherichia coli : changing epidemiology and clinical impact. Curr Opin Infect Dis 2010;23:320-6. DOI |
15 | Yiee J, Wilcox D. Management of fetal hydronephrosis. Pediatr Nephrol 2008;23:347-53. DOI ScienceOn |
16 | Jaksic E, Bogdanovic R, Artiko V, Saranovic DS, Petrasinovic Z, Petrovic M, et.al. Diagnostic role of initial renal cortical scintigraphy in children with the first episode of acute pyelonephritis. Ann Nucl Med 2011;25:37-43. DOI ScienceOn |
17 | Piepsz A, Gordon I, Hahn K. Paediatric nuclear medicine. Eur J Nucl Med 1991;18:41-66. |
18 | Williams G, Craig JC. Prevention of recurrent urinary tract infection in children. Curr Opin Infect Dis 2009;22:72-6. DOI ScienceOn |
19 | Lavocat MP, Granjon D, Guimpied Y, Dutour N, Allard D, Prevot N, et al. The importance of 99mTc-DMSA renal scintigraphy in the follow-up of acute pyelonephritis in children: comparison with urographic data. Nucl Med Commun 1998;19:703-10. DOI ScienceOn |
20 | Ferraro MJ, Craig WA, Dudley MN. Performance standards for antimicrobial susceptibility testing. An NCCLS global informational supplement. 12th. 2002;22:37-46. |
21 | Shaikh N, Morone NE, Bost JE, Farrell MH. Prevalence of urinary tract infection in childhood. Pediatr Infect Dis J 2008;27:302-8. DOI ScienceOn |
22 | Noemia PG, Angelica M. Febrile urinary tract infection: Escherichia coli susceptibility to oral antimicrobials. Pediatr Nephrol 2002;17:173-6. DOI ScienceOn |
23 | American academy of pediatrics, steering committee on quality improvement and management, subcommittee on urinary tract infection. Urinary tract infection : Clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011;128:595-610. DOI ScienceOn |
24 | Smith T, Evans K, Lythgoe MF, Anderson PJ, Gordon I . Radiation dosimetry of technetium-99m-DMSA in children. J Nucl Med 1996;37:1336-42. |
25 | Paquin AJ. Ureterovesical anastamosis: the description and evaluation of a technique. J Urol 1959;82:573-83. |
26 | Chand DH, Rhoades T, Poe SA, et al. Incidence and severity of vesicoureteral reflux in children related to age, gender, race and diagnosis. J Urol 2003;170:1548-50. DOI ScienceOn |
27 | Brigante G, Luzzaro F, Perilli M, Lombardi G, Coli A, Rossolini GM, et al. Evolution of CTX-M-type beta-lactamases in isolates of Escherichia coli infecting hospital and community patients. Int J Antimicrob Agents 2005;25:157-62. DOI ScienceOn |
28 | Rushton HG. The evaluation of acute pyelonephritis and renal scarring with technetium 99m-dimercaptosuccinic acid renal scintigraphy: evolving concepts and future directions. Pediatr Nephrol 1997;11:108-20. DOI ScienceOn |
29 | Brun-Buisson C, Legrand P, Phillippon A, Montravers F, Ansquer M, Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 1987;2:302-6. |
30 | Lohr JA, Portilla MG, Geuder TG, Dunn ML, Dudley SM. Making a presumptive diagnosis of urinary tract infection by using a urinalysis performed in an on-site. Laboratory J Pediatr 1993;122:22-5. DOI |
31 | Pai H. The characteristics of extended-spectrum beta-lactamases in Korean isolates of Enterobacteriaceae. Yonsei Med J 1998;39:514-9. |
32 | Lee JW, Shin JS, Seo JW, Lee MA, Lee SJ. Incidence and risk factors for extended-spectrum betalactamase-producing Escherichia coli in community-acquired childhood urinary tract infection. J Korean Soc Pediatr Nephrol 2004;8:214-22. |
33 | Topaloglu R, Er I, Dogan BG, Bilginer Y, Ozaltin F, Besbas N, et al. Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children. Pediatr Nephrol 2010;25:919-25. DOI ScienceOn |
34 | Kim NH, Lee JA, Kim YK, Choi EH, Ha IS, Lee HJ, Choi Y. Risk factors of urinary tract infections due to extended-spectrum beta-lactamase producing Escherichia coli in children. Korean J Pediatr 2004;47:164-9. |
35 | Mo EH, Nam IH, Park KD. Protein C as a differential marker for bacterial infection among pediatric patients with fever. Korean J Pediatr 2004;47:839-43. |
36 | Jung JI, Lim DH, Yim HE, Park MS, Yoo KH, Hong YS, et al. Fever duration and renal scar in pediatric urinary tract infection. J Korean Soc Pediatr Nephrol 2008;12:70-7. DOI |
37 | Hellstrom A, Hanson E, Hansson S, Hjalmas K, Jodal U. Association between urinary symptoms at 7 years old and previous urinary tract infection. Arch Dis Child 1991;66:232-4. DOI ScienceOn |
38 | Marild S, Jodal U. Incidence rate of first-time symptomatic urinary tract infection in children under 6 years of age. Acta Paediatr 1998;87:549-52. DOI ScienceOn |
![]() |